GLSI
Income statement / Annual
Last year (2024), Greenwich LifeSciences, Inc.'s total revenue was $0.00,
and the percentage change from the previous year is not available.
In 2024, Greenwich LifeSciences, Inc.'s net income was -$15.79 M.
See Greenwich LifeSciences, Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
| Period Ended |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
| Operating Revenue |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Cost of Revenue |
$3.61 K
|
$3.61 K
|
$3.61 K
|
$3.61 K
|
$3.61 K
|
$3.61 K
|
$3.61 K
|
$3.61 K
|
| Gross Profit |
-$3.61 K
|
-$3.61 K
|
-$3.61 K
|
-$3.61 K
|
-$3.61 K
|
-$3.61 K
|
-$3.61 K
|
-$3.61 K
|
| Gross Profit Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
| Research and Development Expenses |
$12.95 M
|
$7.70 M
|
$6.48 M
|
$3.56 M
|
$1.06 M
|
$2.61 M
|
$1.27 M
|
$1.22 M
|
| General & Administrative Expenses |
$3.06 M
|
$1.63 M
|
$1.56 M
|
$1.04 M
|
$806.19 K
|
$818.89 K
|
$419.64 K
|
$0.00
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$3.06 M
|
$1.63 M
|
$1.56 M
|
$1.04 M
|
$806.19 K
|
$818.89 K
|
$419.64 K
|
$346.81 K
|
| Other Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Operating Expenses |
$16.01 M
|
$9.33 M
|
$8.04 M
|
$4.60 M
|
$1.86 M
|
$3.43 M
|
$1.69 M
|
$1.57 M
|
| Cost And Expenses |
$16.01 M
|
$9.33 M
|
$8.04 M
|
$4.60 M
|
$1.86 M
|
$3.43 M
|
$1.69 M
|
$1.57 M
|
| Interest Income |
$223.01 K
|
$436.06 K
|
$215.02 K
|
$27.37 K
|
$832.00
|
$0.00
|
$0.00
|
$0.00
|
| Interest Expense |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Depreciation & Amortization |
$3.61 K
|
$3.61 K
|
$3.61 K
|
$3.61 K
|
$3.61 K
|
$3.61 K
|
$3.61 K
|
$3.61 K
|
| EBITDA |
-$15.79 M |
-$9.32 M |
-$8.04 M |
-$4.59 M |
-$1.86 M |
-$3.42 M |
-$1.69 M |
-$1.57 M |
| EBITDA Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
| Operating Income Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
| Total Other Income/Expenses Net |
$223.01 K
|
$436.06 K
|
$215.02 K
|
$27.37 K
|
$832.00
|
$0.00
|
$0.00
|
$0.00
|
| Income Before Tax |
-$15.79 M
|
-$8.89 M
|
-$7.83 M
|
-$4.57 M
|
-$1.86 M
|
-$3.43 M
|
-$1.69 M
|
-$1.57 M
|
| Income Before Tax Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
| Income Tax Expense |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$3.00
|
| Net Income |
-$15.79 M
|
-$8.89 M
|
-$7.83 M
|
-$4.57 M
|
-$1.86 M
|
-$3.43 M
|
-$1.69 M
|
-$1.57 M
|
| Net Income Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
| EPS |
-1.21 |
-0.69 |
-0.61 |
-0.35 |
-0.15 |
-0.29 |
-0.14 |
-0.13 |
| EPS Diluted |
-1.21 |
-0.69 |
-0.61 |
-0.35 |
-0.15 |
-0.29 |
-0.14 |
-0.13 |
| Weighted Average Shares Out |
$13.01 M
|
$12.85 M
|
$12.91 M
|
$12.94 M
|
$12.70 M
|
$11.74 M
|
$11.97 M
|
$11.74 M
|
| Weighted Average Shares Out Diluted |
$13.01 M
|
$12.85 M
|
$12.91 M
|
$12.94 M
|
$12.70 M
|
$11.74 M
|
$11.97 M
|
$11.74 M
|
| Link |
|
|
|
|
|
|
|
|
